New drug trial offers hope for Tough-to-Treat lung cancer
NCT ID NCT07203053
Summary
This study is testing an experimental drug called tarlatamab for people with advanced small cell lung cancer that has worsened after initial treatment. The trial will enroll 48 participants who are less physically active due to their disease. The main goal is to see if the drug helps patients live longer, with treatment continuing until the cancer grows again or side effects become too severe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTENSIVE STAGE LUNG SMALL CELL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AO San Giovanni Addolorata
Roma, Italy
Contact
-
CHU Angers
Angers, France
Contact
-
Geneva University Hospitals
Geneva, Switzerland
Contact
-
HFR - Hôpital cantonal
Fribourg, Switzerland
Contact
-
Henry Dunant Hospital Center
Athens, Greece
Contact
-
Hospital General Universitario Alicante
Alicante, Spain
Contact
-
Hospital Universitatrio Puerta del Hierro
Madrid, Spain
Contact
-
Hospital Universitatrio Vall d'Hebron
Barcelona, Spain
Contact
-
Hospital de la Santa Creu I Sant Pau
Barcelona, Spain
Contact
-
Hôpital Nord de Marseille
Marseille, France
Contact
-
ICO Hospitalet H. Duran I Reynals / H. Bellvitge
Barcelona, Spain
Contact
-
Institut Bergonie
Bordeaux, France
Contact
-
Instituto Europeo di Oncologia (IEO)
Milan, Italy
Contact
-
Irccs Irst
Meldola, Italy
Contact
-
Istituto Nazionale Tumori "Regina Elena"
Roma, Italy
Contact
-
Kantonsspital Baden
Baden, Switzerland
Contact
-
Kantonsspital St.Gallen
Sankt Gallen, Switzerland
Contact
-
Lyon - Centre Léon Bérard
Lyon, France
Contact
-
Santa Maria della Misericordia Hospital
Perugia, Italy
Contact
Conditions
Explore the condition pages connected to this study.